| Prod Model: |
HY05-A |
| Markets: |
North America,South America,Eastern Europe,Southeast Asia,Africa,Oceania,Mid East,Eastern Asia,Western Europe |
| Positive Clinical Trail Proved That: |
CE, RoHS, ISO9001 and ISO13485 Certified |
| Type: |
Physical Therapy |
Product Description
Semiconductor Nasal-Type Medical Soft Laser Therapy Device (HY05-A)
Application Range:
Hyperviscosity, hyperlipemia, hyperlipidemia, hypertension, diabetes, ischemic heart and cerebral vascular disease caused by ischemic cardiovascular and cerebrovascular diseases. It is also has good curative on the Rhinitis, allergic rhinitis, acute rhinitis, chronic rhinitis, sinusitis and nasal polyps.
Therapeutic Principle:
The Rhinitis Therapeutic Instrument mainly adopts the special soft laser light which can get through the nasal mucosa of the human body. The soft laser light is featured mild working rate and could be fully and safety absorbed by the nasal tissue of the human body. This kind of laser light has a special repair function to the nasal mucosa of the rhinitis patients. The repaired nasal mucosa could secrete antibacterial material including lysozyme as normal mucosa and restart the normal cleaning function of the swinging cilia on the nasal mucosa. In a word, the treatment method of Rhinitis Therapeutic Instrument is based on the fundamental principle of repairing and improving the body's natural immune system.
Function and Performance:
The light quantum entering into the capillary vessels of the nasal mucosa could reduce the blood viscosity; Accelerate the blood the circulation within the nasal tissues. Enhance local blood oxygen saturation, accelerate the absorption and metabolism of nasal tissue to inflammatory substances, eliminate and reduce the nasal obstruction caused by nasal swelling.
Promoting the secretion of lysozyme and phagocytes within the nasal mucosa, improving the immunization and sterilization function of the nasal mucosa. And improving the nasal antivirus/germs ability and the anti-anaphylaxis ability.
Accelerate the convergence of the damaged nasal mucosa, repair damaged blood capillary and prevent the regular nosebleed,
Accelerate and improve the swinging of cilia on the nasal mucosa. Enhance the nasal function and strengthen the detoxification ability of the nasal mucosa.
Features:
The only product with code number for the treatment of rhinitis is approved by SFDA and exact effect.
No medical or chemical components, without pain, damage or stimulation during treatment.
Short treatment time, 15-20 mines each time.
Small in size, easy to carry. It is very compact and portable.
LCD display screen and with easy operation buttons.
Two output modes: Pulse and Continues.
Pluggable laser wire, more convenience in use and easier maintenance.
HUBEI YJT Technology Co., Ltd, established in January of 2005, is a high-tech enterprise specialized in the research & development, production and sale of various medical laser/physical therapy instruments.
Qualification
Specialized in the LLLT series, HNC always takes the products quality as the life. With more than 5, 000 square meters sterilized workshop which coordinate with GMP standard, 4PCS individual fully-automatic production lines. HNC has passed ISO9001 and ISO13485 certificates, and all of HNC's laser treatment instrument series are approved by CE and RoHS certificates.
Innovation
The company has the most advanced medical laser R & D center in China. With more than thirty senior engineers and experts in the field of optoelectronics, HNC successfully developed many global leading semiconductor laser treatment instrument and other medical products with independent intellectual property rights, and have won the related national patents over 30 items.
Overseas Marketing
All of the products are not only popular in domestic market, but also under hot-selling in other Asian and European countries. The distribution channel of HNC brand covers more than 50 countries. We wish to establish the long term business relationship with overseas partners, agent and OEM and ODM are warmly welcome.
